Strategic partnerships Enlighten Mobility has active and recent partnerships including Gravitrex for rehabilitation technology and a prior collaboration with Nationwide Children’s Hospital, indicating openness to co-development and joint go-to-market efforts that can be leveraged for selling integrated neuromotor care solutions.

Acquisition track The EDNA portfolio was acquired by AngelEye Health, suggesting a potential interest from buyers or investors in neuromotor assessment tools and a pattern of asset-focused transactions that could inform future licensing, resale, or strategic collaboration opportunities.

Early detection focus Historical work on GMat Neuromotor Screening and early detection platforms positions Enlighten Mobility to address NICU to early intervention needs, presenting sales opportunities to NICUs, pediatric hospitals, and family-engagement service providers seeking screening capabilities.

Financing signals Previous financing activity and small current revenue implies a growth-ready profile; prospects may include grant programs, venture partners, and hospital systems looking to expand neuromotor care capabilities through funded pilots or shared-risk deployments.

Market readiness Active interest from healthtech and rehabilitation stakeholders, combined with a clear positioning in neuromotor care and resilience initiatives, suggests opportunities to cross-sell rehabilitation tech, assessment tools, and advisory services to hospitals and care networks seeking integrated solutions.